Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers discover that children who survive cancer have socioeconomic challenges.

2.

Breast Cancer Patients Living Longer Post-Medicaid Expansion

3.

enhancing survivors of brain tumors' quality of life.

4.

A Chemo-Free Option for Some Advanced Endometrial Cancers?

5.

The Boom in ADHD Coaching Has Few Rules


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot